Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Commercial Instrument to Isolate and Treat Circulating Tumor Cells

April 21, 2014 By DeNovo Sciences

DeNovo Sciences attended this year’s AACR Conference where the Company released its first commercial instrument, the JETTA100 and associated consumables.

This newly developed technology is the first of its kind where Circulating Tumor Cells (CTC) are isolated and treated with Immunochemistry, DNA FISH, mRNA FISH, and PCR chemistries on the manual JETTA100 instrument. The JETTA100 is the precursor system to the Company’s fully automated JETTA400, to be released mid-year 2014.  In addition to instrumentation, the Company has developed both general and specific reagents for Breast, Prostate and Colorectal Cancers for use in the Research Market.  

“With the commercial introduction of our JETTA100 System and line of consumables at AACR, DeNovo will be able to take advantage of the remaining nine months of 2014 to generate positive revenues”, says Mark Powelson, the Company’s Chief Commercial Officer.  “Even though our products are only focused in the Research Market today, we will begin preparing to take our full line of products through the FDA process later this year.” Powelson went on to say, “This year’s AACR Conference delivered the perfect audience for us to introduce our first product and we are looking forward to release our automated systems at the American Society of Clinical Oncology Conference in June this year.”

One of the keys to monitoring metastatic disease is to understand how these rare cells migrate to other tissue or organs.  With the ability to recover the bulk of these cells from a liquid or small tissue sample, it will provide researchers the ability to better monitor CTC activity and migration patterns.  

CTCs have been shown in many studies to be possible biomarkers for metastasis and may be instrumental for the spread of the disease. Key to monitoring metastatic disease is the understanding of how these rare cells migrate to other parts of a patient’s body.  The ability to recover high percentages of these cells enable researchers to better track CTC activity and monitor the effectiveness of a specific cancer treatment.

For more information, visit DeNovo Sciences.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech